About the Authors
- Richard Kim
-
Affiliation Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
- Michael J. Schell
-
Affiliation Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
- Jamie K. Teer
-
Affiliation Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America
- Danielle M. Greenawalt
-
Current address: AstraZeneca, iMED Oncology, Waltham, MA, United States of America
Affiliation Merck Co, Inc., Boston, MA, United States of America
- Mingli Yang
-
Affiliation Gibbs Cancer Center and Research Institute, Spartanburg, SC, United States of America
- Timothy J. Yeatman
-
* E-mail: yeatman@gibbscc.org
Affiliation Gibbs Cancer Center and Research Institute, Spartanburg, SC, United States of America
Competing Interests
DMG was employed previously by Merck Co, Inc and currently by AstraZeneca. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RK MJS TJY. Performed the experiments: MJS JKT DMG. Analyzed the data: RK MJS JKT DMG MY TJY. Contributed reagents/materials/analysis tools: MJS JKT TJY. Wrote the paper: RK MJS JKT MY TJY.